TY  - JOUR
T1  - Combination therapy of cytotoxic t-lymphocyte-associated antigen 4 (ctla-4) and programmed death 1 (pd1) blocker, check point inhibitors for treatment of patients with advanced and recurrent epithelial ovarian cancer
A1  - Farghaly,S.A.
JO  - European Journal of Gynaecological Oncology
VL  - 38
IS  - 1
SP  - 7
EP  - 9
SN  - 2709-0086
Y1  - 2017
ER  -